Phase I/II trial of bendamustine, ixazomib, and dexamethasone in relapsed/refractory multiple myeloma

por Dhakal, Binod, D’Souza, Anita, Hamadani, Mehdi, Arce-Lara, Carlos, Schroeder, Katrina, Chhabra, Saurabh, Shah, Nirav N., Gauger, Katelyn, Keaton, Taylor, Pasquini, Marcelo, Hari, Parameswaran
Publicado 2019